Table 1. Correlation between clinical characteristics and CD164 expression in human glioma.
| Clinical characteristics | Patients (%) | CD164 expression | ||
|---|---|---|---|---|
| H-score (Mean ± SD) | p | |||
| Age | >40 | 54 (54%) | 16.11 ± 14.94 | |
| ≤40 | 46 (46%) | 15.46 ± 13.85 | 0.821 | |
| Sex | Male | 56 (56%) | 17.63 ± 16.81 | |
| Female | 44 (44%) | 13.34 ± 9.80 | 0.135 | |
| Tumor cell type | Normal brain tissue | 20 (20%) | 4.72 ± 3.50 | |
| Astrocytoma | 78 (78%) | 18.32 ± 14.89 | <0.001 | |
| Oligodendroglioma | 2 (2%) | 22.18 ± 0.48 | p for trend = 0.081 | |
| Grade* | 0 (Normal brain tissue) | 20 (20%) | 4.72 ± 3.50 | |
| II | 32 (32%) | 17.30 ± 16.85 | <0.001 | |
| Above II | 42 (42%) | 20.95 ± 12.96 | p for trend <0.001 | |
*Grades II∼III: 15 samples; Grade III: 15 samples; Grades III∼IV: 6 samples; Grade IV: 6 samples. Six unknown-grade samples were excluded. Tumor grading according to WHO histological grading system.